2
BOULDER COLORADO BRUSSELS LIESTAL PLANKSTADT CHENÔVE CAPONAGO BERGAMO FRANKFURT LATINA CordenPharma Switzerland is a cGMP manufacturer of advanced pharmaceutical intermediates and APIs, with particular focus on the production of small molecules, lipids, GalNac and carbo- hydrates. Located 15 km from Basel in Liestal, Switzerland, the facility was started in 1987 by Sygena AG before being purchased by Genzyme Pharmaceuticals in 1994. In 2011, the facility was acquired by ICIG and became Corden Pharma Switzerland LLC. CordenPharma Switzerland brings over 30 years of experience and expertise in the pharmaceutical manufacturing arena with a particular focus on chemistry, technology and project man- agement. The cGMP facility has been fully inspected by global regulatory agencies including, but not limited to, Swissmedic, FDA and PMDA (Japan). APIs: Clinical & Commercial API Support Services Integrated Supply Drug Product Facilities: CordenPharma Caponago (IT) CordenPharma Plankstadt (DE) Related Technology Platforms: CORDENPHARMA SWITZERLAND API FACILITY Small Molecules Peptides, Lipids & Carbohydrates

CORDENPHARMA SWITZERLAND API FACILITY · COLORADO BRSSELS LIESTAL PLANKSTADT CHENÔVE CAPONAGO BERAMO FRANKFURT LATINA CordenPharma Switzerland is a cGMP manufacturer of advanced

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

  • BOULDER

    COLORADO

    BRUSSELS

    LIESTAL

    PLANKSTADT

    CHENÔVE

    CAPONAGO

    BERGAMO

    FRANKFURT

    LATINA

    CordenPharma Switzerland is a cGMP manufacturer of advanced

    pharmaceutical intermediates and APIs, with particular focus

    on the production of small molecules, lipids, GalNac and carbo-

    hydrates. Located 15 km from Basel in Liestal, Switzerland, the

    facility was started in 1987 by Sygena AG before being purchased

    by Genzyme Pharmaceuticals in 1994. In 2011, the facility was

    acquired by ICIG and became Corden Pharma Switzerland LLC.

    CordenPharma Switzerland brings over 30 years of experience

    and expertise in the pharmaceutical manufacturing arena with

    a particular focus on chemistry, technology and project man-

    agement. The cGMP facility has been fully inspected by global

    regulatory agencies including, but not limited to, Swissmedic,

    FDA and PMDA (Japan).

    APIs:

    Clinical & Commercial

    API Support Services

    Integrated Supply Drug

    Product Facilities:

    CordenPharma Caponago (IT)

    CordenPharma Plankstadt (DE)

    Related Technology Platforms:

    CORDENPHARMA SWITZERLANDAPI FACILITY

    Small Molecules Peptides, Lipids& Carbohydrates

  • Core Capabilities

    » New process development and / or technology

    transfer for small molecules or lipids

    » Manufacture of APIs & Advanced GMP

    Intermediates from gram-scale to multi-kilos

    » Flexible, multi-purpose manufacturing plants

    with reactors up to 2,500 L

    » On-site, comprehensive analytical development

    & QC facilities

    » Wide range of chemical capability (hydrogenation,

    coupling chemistry & organometallics)

    » CordenPharma Centre of Excellence for Small

    Molecule Chemical Development

    Capacities / Technologies

    » Reactors from 20 L to 2,500 L

    (Total Capacity – 27,000 L)

    » Materials of construction: stainless steel,

    glass-lined & Hastelloy

    » Reactions conditions: -90°C to 160°C and

    1mbar to 20bar (vacuum/pressure)

    » Dryers: vacuum tray, filter & conical

    (also lyophilization)

    » Chromatographic capabilities from small to

    large-scale (HPLC & MPLC)

    SWITZERLAND FACILITY FACTS

    www.cordenpharma.com/

    contact-us

    www.cordenpharma.com/

    facilities/liestal